External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients

[1] Schröder FH(2014)Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up The Lancet 384 2027-2035

[2] Hugosson J(2014)Radical prostatectomy or watchful waiting in early prostate cancer N Engl J Med 370 932-942

[3] Roobol MJ(2011)Radiotherapy and short-term androgen deprivation for localized prostate cancer N Engl J Med 365 107-118

[4] Bill-Axelson A(2016)Recommendations en onco-urologie 2016–2018 du CCAFU : cancer de la prostate Prog En Urol 27 S95-S143

[5] Holmberg L(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629

[6] Garmo H(2006)Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy Eur Urol 49 1019-1027

[7] Jones CU(2012)Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores Eur Urol 61 480-487

[8] Chetner MP(2014)External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer BJU Int 114 E113-119

[9] Rotman M(2012)Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer Eur Urol 61 584-592

[10] Rozet F(2007)Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy Eur Urol 52 29-37

[1] Schröder FH(2014)Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up The Lancet 384 2027-2035

[2] Hugosson J(2014)Radical prostatectomy or watchful waiting in early prostate cancer N Engl J Med 370 932-942

[3] Roobol MJ(2011)Radiotherapy and short-term androgen deprivation for localized prostate cancer N Engl J Med 365 107-118

[4] Bill-Axelson A(2016)Recommendations en onco-urologie 2016–2018 du CCAFU : cancer de la prostate Prog En Urol 27 S95-S143

[5] Holmberg L(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629

[6] Garmo H(2006)Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy Eur Urol 49 1019-1027

[7] Jones CU(2012)Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores Eur Urol 61 480-487

[8] Chetner MP(2014)External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer BJU Int 114 E113-119

[9] Rotman M(2012)Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer Eur Urol 61 584-592

[10] Rozet F(2007)Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy Eur Urol 52 29-37